Final results for the year ended 31 December 2025

AI SummaryClose X

Cizzle Biotechnology Holdings plc has published its Annual Report and Financial Statements for the year ended 31 December 2025, detailing its progress as a UK-based diagnostics developer of early cancer tests. The report is available via a provided link and will be accessible on the National Storage Mechanism and the Company's website. The company is focused on its CIZ1B biomarker, a non-invasive blood test for early lung cancer detection, and has entered into commercial royalty-bearing arrangements and collaborations.

Disclaimer*

UK 100

Latest directors dealings